The chemical substance known as Urea, N-(3-aminophenyl)-N'-[1-(3,3-dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-, (R)-, with CAS number 155412-88-7, is a complex organic compound characterized by its urea functional group and a multi-ring structure that includes a benzodiazepine moiety. This compound features a chiral center, indicating that it exists in two enantiomeric forms, with the (R)- configuration being specified. The presence of the 3-aminophenyl group suggests potential interactions with biological targets, making it of interest in medicinal chemistry. The compound's structure includes various functional groups, such as ketones and amines, which may contribute to its reactivity and solubility properties. Its potential applications could span pharmacology, particularly in the development of therapeutic agents, due to the benzodiazepine framework, which is known for its anxiolytic and sedative effects. However, specific details regarding its physical properties, such as melting point, solubility, and biological activity, would require further investigation through experimental data.

Urea,N-(3-aminophenyl)-N'-[1-(3,3-dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-, (R)-

155412-88-7: The chemical substance known as Urea, N-(3-aminophenyl)-N'-[1-(3,3-dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-, (R)-, with CAS number 155412-88-7, is a complex organic compound characterized by its urea functional group and a multi-ring structure that includes a benzodiazepine moiety. This compound features a chiral center, indicating that it exists in two enantiomeric forms, with the (R)- configuration being specified. The presence of the 3-aminophenyl group suggests potential interactions with biological targets, making it of interest in medicinal chemistry. The compound's structure includes various functional groups, such as ketones and amines, which may contribute to its reactivity and solubility properties. Its potential applications could span pharmacology, particularly in the development of therapeutic agents, due to the benzodiazepine framework, which is known for its anxiolytic and sedative effects. However, specific details regarding its physical properties, such as melting point, solubility, and biological activity, would require further investigation through experimental data.

<p>CCK-B Receptor Antagonist 2 is a potent and orally active antagonist of Gastrin/CCK-B (IC50: 0.43 nM). It also inhibits gastrin/CCK-A activity (IC50: 1.82 μM).</p>

CAS 155412-88-7

Urea,N-(3-aminophenyl)-N'-[1-(3,3-dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-, (R)-

CCK-B Receptor Antagonist 2

Ref: TM-T10707